Emildap Trio 10mg/500mg/100mg Tablet is a triple combination medication that contains Dapagliflozin, Metformin, and Sitagliptin to help manage blood glucose levels. Dapagliflozin helps remove excess sugar from the body through urine by reducing glucose reabsorption in the kidneys. Metformin helps decrease glucose production in the liver and improves the body’s response to insulin. Sitagliptin increases the levels of hormones that support insulin release and help control blood sugar after meals. The combined action of these medicines helps improve glycemic control and maintain more stable blood glucose levels throughout the day. Proper blood sugar management is important for reducing the risk of complications associated with diabetes. This medication is usually taken as part of a comprehensive diabetes care plan that includes healthy eating habits and regular exercise. When used under medical supervision, Emildap Trio Tablet supports effective glucose regulation and overall metabolic health.